Science & Technology
SBIR Phase I: Multiplexed High Throughput Discovery of Functional RNA-Targeting Small Molecules Via Next-Generation Sequencing
National Science Foundation
Opportunity #: 2507762
Award Ceiling
$303K
Award Floor
$303K
Close Date
Jan 31, 2026
Total Funding
$303K
Expected Awards
1
Posted Date
May 9, 2025
Cost Sharing Required
No
Grants.gov ID
sbir-2507762
Description
SBIR Phase Phase I award: "SBIR Phase I: Multiplexed High Throughput Discovery of Functional RNA-Targeting Small Molecules Via Next-Generation Sequencing" awarded to Endura Therapeutics, Inc. in South San Francisco, California. Funded by National Science Foundation. Award amount: $303,445. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.